PP02 Renin-Angiotensin-Aldosterone System - Bench to Bedside

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Cardiovascular Endocrinology-Basic
Friday, April 1, 2016: 11:30 AM-11:45 AM
Room 156 (BCEC)
Eleanor Davies, PhD, BSc, University of Glasgow, Glasgow, United Kingdom and Celso E. Gomez-Sanchez, MD, Univ of Mississippi Med Ctr, Madison, MS

Nothing to Disclose: ED, CEG Disclosure Not Provided: NC, FM
Carmela Maniero, MD1, Junhua Zhou, BMBS, MMed1, Elena AB Azizan, PhD2, Giles S H Yeo, PhD3, Brian Y H Lam, PhD3, Sudeshna G Neogi, PhD4, Wanfeng Zhao, PhD5 and Morris J Brown, MSc MD FRCP FAHA FMedSci1, (1)Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom
(2)Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur, Malaysia
(3)University of Cambridge Metabolic Research Laboratories, Cambridge, United Kingdom
(4)Department of Clinical Biochemistry, Genomics CoreLab, Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), Cambridge, United Kingdom
(5)Human Research Tissue Bank, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Poster Board Number: FRI 572
Janet H Leung, MD1, Jessica Lasky-Su, PhD2, Jonathan S Williams, MD, MS3 and Gordon H Williams, MD1, (1)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
(2)Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
(3)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Poster Board Number: FRI 575
Takumi Kitamoto, MD1, Sachiko Suematsu2, Yoko Matsuzawa, MD, PhD2, Jun Saito, MD, PhD2, Masao Omura, MD, PhD2 and Tetsuo Nishikawa, MD, PhD2, (1)Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
(2)Endocrinology and Diabetes Center, Yokohama Rosai Hosp, Yokohama, Japan
Poster Board Number: FRI 573
Hiroki Shimada, BS1, Ryo Ito, PhD1, Ikuko Sato, BS1, Emiko Sato, PhD2, Atsushi Yokoyama, PhD1 and Akira Sugawara, MD, PhD1, (1)Dept of Molecular Endocrinology, Tohoku Univ Grad School of Med, Sendai, Japan
(2)Dept of Clinical Pharmacology and Therapeutics, Tohoku Univ Grad Sch of Pharmaceutical Sciences, Sendai
Poster Board Number: FRI 574


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire